Luke T. Shannon, Shareholder, Polsinelli PC to Speak at TKG’s Paragraph IV Patent Litigation in the 2019 Landscape:Trends and Significant Developments Explored
TKG/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Luke T. Shannon, Shareholder, Polsinelli PC will speak at TKG’s webcast entitled: “Paragraph IV Patent Litigation in the 2019 Landscape: Trends and Significant Developments Explored!”. This event is scheduled for April 10, 2019 from 3:00 PM to 4:00 PM ET.
- (1888PressRelease) March 14, 2019 - The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Luke T. Shannon, Shareholder, Polsinelli PC will speak at the Knowledge Group’s webcast entitled: “Paragraph IV Patent Litigation in the 2019 Landscape: Trends and Significant Developments Explored!”. This event is scheduled for Wednesday, April 10, 2019 from 3:00 PM to 4:00 PM (ET).
For further details, please visit:
https://www.theknowledgegroup.org/webcasts/paragraph-iv-patent-certifications-2/
About Luke T. Shannon
Luke T. Shannon is a shareholder in the Chicago office of Polsinelli PC and a member of the firm’s Hatch-Waxman Litigation Practice Group. Luke has been practicing for more than a decade and handles all types of IP disputes. His recent focus includes cases involving small molecules, compositions and formulations, polymorphs, combinatorial chemistry, methods of treatment, and pharmaceutical salt forms.
About Polsinelli PC
Polsinelli is an Am Law 100 firm with more than 825 attorneys in 21 offices. Ranked #30 for Client Service Excellence and #10 for best client relationships among 650 U.S. law firms, Polsinelli was also named among the top 30 best-known firms in the nation. The firm’s attorneys provide value through practical legal counsel infused with business insight, and focus on health care, financial services, real estate, intellectual property, mid-market corporate, labor and employment, and business litigation.
Event Synopsis:
In recent years, generic drug manufacturers have been grappling with filing Paragraph IV (PIV) challenges to successfully gain market entry. The significant increase in the number of patent challenges on brand drugs, specifically on blockbuster drugs, is expected to continue in 2019. However, with the evolving regulatory paradigm, manufacturers become vulnerable to a myriad of risks, including the likelihood of a PIV lawsuit.
In the changing PIV landscape, it is imperative that pharmaceutical companies are abreast of the latest developments to avoid patent infringement, more so, the complexities of a PIV litigation. They must be well-versed with the litigation know-hows to efficiently and effectively win a PIV dispute.
Listen as a panel of distinguished professionals and thought leaders assembled by The Knowledge Group provide an in-depth discussion of the significant trends and developments in Paragraph IV Patent Litigation. Speakers will also offer best strategies that will help manufacturers and counsel in this evolving landscape.
Key issues that will be covered in this course are:
• Paragraph IV Patent Litigation and the Abbreviated New Drug Application (ANDA): Recent Trends and Developments
• Notable PIV Cases and Court Rulings
• Best Application Strategies
• Significant Litigation Techniques
• What Lies Ahead
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam